Use of the R(+) enantiomers could increase safety and efficiency by reducing β1- and β2-related side effects in the treatment of IH and possibly other types of vascular anomalies in which SOX18 plays a role (64, 65). Here, SOX18 is linked to isolated hemihyperplasia.